Načítá se...
IGF-1 in Friedreich’s Ataxia – proof-of-concept trial
BACKGROUND: Friedreich’s ataxia is an autosomal recessive, severely incapacitating disorder. There is little objective evidence regarding FRDA management. Abnormalities in the insulin/insulin-like growth factor 1 (IGF-1) system (IIS) signalling pathway were thought to play a role in the physiopathol...
Uloženo v:
| Vydáno v: | Cerebellum Ataxias |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4552279/ https://ncbi.nlm.nih.gov/pubmed/26331034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2053-8871-1-10 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|